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Background: Retroviruses HTLV-1 and HTLV-2 have homologous genomic structures but differ significantly
in pathogenicity. HTLV-1 is associated with Adult T cell Leukemia (ATL), whereas infection by HTLV-2 has no
association with neoplasia. Transformation of T lymphocytes by HTLV-1 is linked to the capacity of its oncoprotein
Tax-1 to alter cell survival and cell cycle control mechanisms. Among these functions, Tax-1-mediated activation of
cellular gene expression via the NF-κB pathway depends on Tax-1 post-translational modifications by ubiquitination
and sumoylation. The Tax-2 protein of HTLV-2B (Tax-2B) is also modified by ubiquitination and sumoylation and
activates the NF-κB pathway to a level similar to that of Tax-1. The present study aims to understand whether
ubiquitination and sumoylation modifications are involved in Tax-2B-mediated activation of the NF-κB pathway.
Results: The comparison of Tax-1 and Tax-2B lysine to arginine substitution mutants revealed conserved patterns
and levels of ubiquitination with notable difference in the lysine usage for sumoylation. Neither Tax-1 nor Tax-2B
ubiquitination and sumoylation deficient mutants could activate the NF-κB pathway and fusion of ubiquitin or
SUMO-1 to the C-terminus of the ubiquitination and sumoylation deficient Tax-2B mutant strikingly restored
transcriptional activity. In addition, ubiquitinated forms of Tax-2B colocalized with RelA and IKKγ in prominent
cytoplasmic structures associated with the Golgi apparatus, whereas colocalization of Tax-2B with the RelA subunit
of NF-κB and the transcriptional coactivator p300 in punctate nuclear structures was dependent on Tax-2B
sumoylation, as previously observed for Tax-1.
Conclusions: Both Tax-1 and Tax-2 activate the NF-κB pathway via similar mechanisms involving ubiquitination and
sumoylation. Therefore, the different transforming potential of HTLV-1 and HTLV-2 is unlikely to be related to
different modes of activation of the canonical NF-κB pathway.
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Human T-cell leukemia viruses type 1 (HTLV-1) and
type 2 (HTLV-2) share a common genomic structure but
differ significantly in their pathogenic properties [1,2].
This difference is generally attributed to the properties
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reproduction in any medium, provided the orboth of which activate gene expression via ATF/CREB
and NF-κB pathways [3]. The transforming activity of
Tax-1 is linked to its ability to activate the NF-κB path-
way, but also to promote cell cycle progression, genome
instability and inactivation of the p53 and pRb tumor
suppressors resulting in the survival and proliferation of
HTLV-1 infected T-cells [4-11].
Because less is known about Tax-2, a comparative
analysis between Tax-1 and Tax-2 is important in order
to reach a better understanding of the differences in
pathogenesis. In a recent review [12], the known featuresd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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discussed. Although Tax-1 and Tax-2B share 85 percent
of amino acid similarity, two basic structural features
differentiate the two proteins. First, a domain outlined
by amino acids 225 and 232 of Tax-1 is responsible for
p100 processing into p52 leading to activation of the
non-canonical NF-κB pathway [13,14]. Second, the C-
terminus of Tax-1 contains a domain involved in micro-
nuclei formation [15] and a PDZ binding motif (PBM)
encompassing the four C-terminal amino acids respon-
sible for the binding to several PDZ domain-containing
proteins [16-18]. In addition, some HTLV-2 subtypes
express shorter versions of Tax-2 (namely Tax-2A and
Tax-2CG) which, contrary to Tax-2B, do not functionally
inactivate p53 [10,19].
Recent studies have demonstrated a hierarchical
sequence of post-translational modifications that control
Tax-1 intracellular localization and transcriptional activ-
ities (reviewed in [20,21]). Phosphorylation-dependent
ubiquitination controls both Tax-1 retention in the
cytoplasm and subsequent targeting to Golgi-associated
structures, in which Tax-1 colocalizes with RelA and
IKKγ leading to activation of the IκB kinase (IKK) com-
plexes [22-25]. These steps determine phosphorylation
and degradation of the NF-κB inhibitor IκBα and the
migration of the active RelA subunit of NF-κB to the
nucleus. In the nucleus, Tax-1 is polysumoylated at
lysine residues K7 and K8 at amino acid positions 280
and 284. Polysumoylation determines the retention of
Tax-1 in the nucleus, the formation of Tax nuclear
bodies (NBs) and the recruitment within these NBs of
various cellular transcription factors, including the RelA
subunit of NF-κB [26] and the transcriptional coactiva-
tor p300 [27]. Thus, phosphorylated and polyubiquiti-
nated Tax-1 molecules in the cytoplasm, as well as
polysumoylated Tax-1 molecules in the nucleus, cooper-
ate for activation of the NF-κB pathway [22,25,28].
The recent findings that Tax-2B is also modified by
ubiquitination and sumoylation [29] and that Tax-1 and
Tax-2B form complexes and colocalize with the same
cellular factors [30] point to a common intracellular
distribution and interactome. To determine whether ubi-
quitination and sumoylation control Tax-2B transcrip-
tional activity and to outline possible differences
between Tax-1 and Tax-2B, we have constructed a series
of Tax-2B mutants with substitution of specific lysine
residues by arginines as well as C-terminal fusions of
these mutants to ubiquitin or SUMO-1. We have com-
pared the ubiquitination and sumoylation status of the
Tax-2B mutants, their intracellular distribution and their
capacity to activate gene expression via the NF-κB path-
way, with the patterns of the corresponding Tax-1
mutants. This study reveals that the transcriptional
activity of the Tax-2B lysine to arginine substitutionmutants and the ubiquitin and SUMO-1 fusions correl-
ate with their ubiquitination and sumoylation status,
suggesting a common mechanism of NF-κB activation
for Tax-1 and Tax-2B.
Results
Mutation of multiple lysine residues determines loss of
ubiquitination and sumoylation of both Tax-1 and Tax-2B
Previous studies indicated that Tax-1 is polysumoylated
at lysine residues K7 and K8 and polyubiquitinated at
the five central lysine residues K4 to K8 [22]. These five
amino acids are maintained with similar sequence envir-
onment in the Tax-2B amino acid sequence. The com-
parative alignment of the Tax-1 and Tax-2B amino acid
sequences is shown in Figure 1. The nomenclature of
the 14 lysine residues in Tax-2B was designed to main-
tain identical numbers for equivalent lysine residues in
the two sequences.
To investigate the role of post-translational modifica-
tions of Tax-2B in activating the NF-κB pathway, we first
constructed Tax-2B lysine to arginine substitution
mutants equivalent to Tax-1 mutants K7-8R (sumoyla-
tion deficient) as well as K4-8R and K1-10R (sumoyla-
tion and ubiquitination deficient) mutants, as described
in [22]. The generated mutants Tax-2 K7-8R, K3ii-8R
and K1-10iR were fused to a C-terminal 6 histidine tag.
Mutants were coexpressed with either HA-Ubiquitin or
HA-SUMO-1 and purified by Ni-NTA pulldown. The
extent of ubiquitination and sumoylation in comparison
with the equivalent Tax-1 mutants is shown in Figure 2.
The ladders of ubiquitinated forms were similar for wild
type Tax-1 and Tax-2B, though a lower rate of mono-
ubiquitination was observed for Tax-2B (Figure 2A). The
abundance of the ubiquitinated forms was progressively
reduced with increasing number of substituted lysine resi-
dues, ultimately leading to undetectable ubiquitinated
forms for the two lysine-less mutants Tax-1 K1-10R and
Tax-2 K1-10iR. Similar patterns of sumoylated forms
for wild type Tax-1 and Tax-2B were also observed
(Figure 2B). Interestingly, although mutations of lysine K7
and K8 completely abolished sumoylation of mutant
Tax-1 K7-8R, as previously reported [22], the equivalent
mutant Tax-2 K7-8R still maintained 81% of sumoylation
as compared to wild type Tax-2B. Moreover, Tax-2 K3ii-
8R, with all 6 central lysine residues mutated to argi-
nines, still had a detectable level of sumoylation (7%).
As expected, when mutants Tax-1 K1-10R and Tax-2
K1-10iR with substitutions of all lysine residues were
analyzed, no sumoylated forms were detected. The pres-
ence of comparable levels of wild type and mutant Tax
proteins was ascertained by Western blot analysis using
an anti-6His antibody (Figure 2C). These results indicate
that Tax-2B central lysine residues K3ii to K8 are the
major targets for ubiquitination, as observed for the
Figure 1 Alignment of the Tax-1 and Tax-2B amino acid sequences. The 10 lysine residues of Tax-1 and the 10 equivalent lysine residues
of Tax-2B are designated K1 to K10. The four additional Tax-2B lysine residues are designated K2i, K3i, K3ii and K10i. The two functional
domains involved in Tax-1-mediated processing of NF-κB p100 and binding to PDZ domain containing protein (PBM) that are divergent in
Tax-2B, are highlighted.
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sumoylation status of Tax-2B mutants was different from
those of corresponding Tax-1 mutants. The fact that
Tax-2 K7-8R sumoylation was reduced to 81% as com-
pared to wild type Tax-2B indicates that lysines K7 and K8
are at least partly involved in Tax-2B sumoylation.
A further reduction to 7% of wild type Tax-2B sumoyla-
tion is observed for mutant K3ii-8R indicating that the
4 lysines K3ii to K6 can also be sumoylated. Thus, con-
trary to Tax-1, lysine residues other that K7 and K8 can be
sumoylated in Tax-2B.Ubiquitination and sumoylation deficiency alters the
intracellular localization of both Tax-1 and Tax-2B
The following series of experiments were designed to
shed light on the controversy regarding the specifics of
the intracellular distribution for Tax-1 and Tax-2B. First,
we developed an anti-Tax-2B rabbit polyclonal antibody
(cf Methods, Additional file 1). Second, the Tax-2B and
Tax-1 genes were cloned in both pcDNA6.2 and pJFE14
expression vectors. We determined that cells transfected
with pJFE-Tax vectors express 20 times more Tax pro-
teins than cells transfected with the pcDNA-Tax vectors
(data not shown). Third, we analyzed the intracellular
distribution of Tax-2B with respect to Tax-1 by immu-
nofluorescence staining using the newly developed anti-Tax-2B antibody in HeLa or 293T cells transfected with
either the high level (pJFE) or the low level (pcDNA)
expression vectors (Figure 3).
The results indicated that Tax-2B had a punctate nu-
clear distribution reminiscent of the Tax-1 nuclear bod-
ies only in 293T cells transfected with pcDNA-Tax-2B
vector. Either high and low level expression of Tax-2B in
HeLa cells or high level expression in 293T cells strongly
limited detection of Tax-2B in the nucleus and resulted
in its accumulation in the cytoplasm. In contrast, Tax-1
NBs were observed in all tested conditions. Note that
expression of Tax-1 using the low level expression vector
in 293T cells resulted in undetectable Tax-1 in the cyto-
plasm and its concentration in Tax NBs in the majority
of the cells. These results suggest that the balance
between the cytoplasmic and nuclear distribution is
more dependent upon the level and cellular background
of expression for Tax-2B than for Tax-1.
Because of the differences described in the preceding
paragraph showing parameters that impact on Tax-2B
distribution in the nucleus, we tested the intracellular
localization of lysine to arginine substitution Tax-2B
mutants in 293T cells transfected with pcDNA vectors
expressing wild type or mutant Tax-2B proteins. Coloca-
lization of Tax-1 with the RelA subunit of NF-κB and
the transcriptional coactivator p300 in NBs is critical for
Tax-1-mediated activation of the NF-κB pathway [27].
Figure 2 Mutation of multiple Tax-1 or Tax-2B lysine residues leads to ubiquitination and sumoylation deficiency. 293T cells were
cotransfected with vectors expressing wild type (WT) or lysine to arginine substitution mutants of Tax-1-6His and Tax-2B-6His, and with vectors
expressing (A) HA-Ubiquitin or (B) HA-SUMO-1. Purification of the ubiquitinated and sumoylated forms was performed by Ni-NTA pulldown and
the purified proteins were analyzed by Western Blot using an anti-HA antibody. (C) Comparable levels of wild type and mutant Tax proteins in
the Ni-NTA pulldown preparations were ascertained by Western blot analysis using an anti-6His antibody. The abundance of the different
species on the blots was estimated, and the percentages relatively to wild type species are indicated under each Western blot image.
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Tax proteins, as well as RelA and p300, by triple im-
munofluorescence staining in 293T cells cotransfected
with vectors expressing wild type or mutant Tax proteins
and p300-HA (Figure 4).
In cells that did not express Tax proteins, overex-
pressed p300-HA was detected only in the nucleus and
displayed a speckled distribution, whereas endogenous
RelA was only detected in the cytoplasm, as previously
reported [27]. As indicated by the intensity of the fluor-
escence staining along a line drawn across the nucleus,
wild type Tax-1 or Tax-2B concentrated within punctate
nuclear structures in which both p300 and RelA were
recruited. The punctate nuclear structures containing
Tax-1, RelA and p300 were previously identified as Tax
NBs by electron microscopy analysis [26]. It is interest-
ing to note that, although both wild type Tax proteinswere also detected in the cytoplasm, Tax-1, but much
less frequently Tax-2B, concentrated with RelA in cyto-
plasmic structures at the boundary of the nucleus (high-
lighted by arrows in Figure 4). This observation will be
further discussed below.
Remarkably, the Tax-2 K7-8R mutant, which main-
tained 52% of ubiquitination and 81% of sumoylation
with respect to wild type Tax-2B, formed nuclear punc-
tate structures in which p300 and RelA colocalized. This
is in marked contrast with the equivalent ubiquitinated
(55%), but non-sumoylated Tax-1 K7-8R mutant, which
was deficient for formation of nuclear bodies but was
able to induce the migration of RelA to the nucleus in a
majority of the cells, as previously demonstrated [22].
Furthemore, Tax-2 K3ii-8R was still partly sumoylated
and both RelA and p300 concentrated in nuclear punc-
tate structures in a significant fraction of the cells,
Figure 3 The intracellular distribution of Tax-2B depends on the level and cellular context for expression. HeLa or 293T cells were
transfected with high level (pJFE) or low level (pcDNA) expression vectors for either Tax-1 or Tax-2B and analyzed by immunofluorescence
staining and confocal microscopy with anti-Tax-1 IgG2a monoclonal antibody or anti-Tax-2B rabbit polyclonal antibody followed by anti-rabbit
or anti-mouse IgG antibodies conjugated to Dylight 488. DIC, differential inference contrast.
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Figure 4 Ubiquitination and sumoylation deficiency alters the intracellular localization of both Tax-1 and Tax-2B. 293T cells were
cotransfected with vectors expressing wild type or mutant Tax-1 or Tax-2B and the transcriptional coactivator p300-HA. The cells were fixed,
stained by triple immunofluorescence staining and analyzed by laser scanning confocal microscopy. Staining of Tax-1 expressing cells was with
anti-Tax-1 IgG2a monoclonal antibody, anti-HA rabbit polyclonal antibody for the detection of p300-HA and anti-RelA IgG1 monoclonal antibody.
For cells expressing Tax-2B, anti-Tax-2B rabbit polyclonal antibody and anti-HA monoclonal IgG2a antibody for the detection of p300-HA and
the anti-RelA IgG1 monoclonal antibody were used. The secondary antibodies were goat anti-mouse IgG2a conjugated to Dylight 488, goat
anti-rabbit IgG conjugated to Dylight 549 and goat anti-mouse IgG1 conjugated to Dylight 649. The profiles of the intensity of the fluorescence
staining along lines crossing the nuclei are shown in the right panels (NE: nuclear envelope). The percentages of ubiquitination and sumoylation
obtained in Figure 2 are indicated for each mutant (Ub/SUMO). White arrows point to cytoplasmic structures that contain Tax-1 and RelA at the
boundary of the nucleus.
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tination and sumoylation deficient Tax-1 K4-8R mutant.
Finally, the ubiquitination and sumoylation deficient
Tax-1 K1-10R and Tax-2 K1-10iR mutants had diffuse
distributions in the cytoplasm and the nucleus and did
not induce the translocation of RelA to the nucleus. We
also observed that endogenous p300 colocalized with
Tax-2B in punctate nuclear structures, as demonstrated
above for overexpressed p300 (Additional file 2). These
results established a direct correlation between ubiquiti-
nation and translocation of RelA to the nucleus as well
as between sumoylation and formation of punctate
nuclear structures in which RelA and p300 were
recruited for both Tax-1 and Tax-2B.
Activation of gene expression via the NF-κB pathway
correlates with the sumoylation and ubiquitination
status of both Tax-1 and Tax-2B
We then investigated the relevance of modification by
ubiquitination and sumoylation in Tax-2B-mediatedFigure 5 Activation of gene expression via the NF-κB pathway correla
293T cells were cotransfected with 50 ng of vectors expressing wild type o
Fifty ng of the phRG-TK Renilla Luciferase vector were added to the reactio
luciferase activity was measured. Mutant Tax-1 and Tax-2B activities were e
the averages of three independent experiments. Comparable levels of wild
Western blot analysis using Tax-1 and Tax-2B antibodies.activation of the NF-κB pathway. We analyzed the cap-
acities of wild type and mutant Tax-2B to activate gene
expression from a construct expressing the luciferase re-
porter gene under the control of a promoter containing
κB binding sites (NF-κB-luc reporter construct). The
results were compared to those obtained for the equiva-
lent wild type and mutant Tax-1 proteins (Figure 5).
Notable differences between Tax-1 and Tax-2B emerged.
Tax-1 K7-8R and K4-8R mutants were defective for NF-
κB activation, thus confirming our previous findings
[22], whereas the homologous Tax-2 K7-8R and K3ii-8R
mutants maintained 70 and 18% of NF-κB activation,
respectively. Both Tax-1 and Tax-2B mutants with all
lysine residues substituted by arginines were defective
for activation of gene expression via the NF-κB pathway.
The expression level of each construct was controlled by
detection with anti-Tax-1 and anti-Tax-2B antibodies.
The fact that both Tax-2 K7-8R and K3ii-8R mutants
were at least partly sumoylated and concentrated with
RelA and p300 in nuclear punctate structures contrarytes with Tax-1 and Tax-2B ubiquitination and sumoylation status.
r mutant Tax-1 or Tax-2B and 250 ng of NF-κB-Luc reporter plasmid.
n to normalize for transfection efficiency. Cells were lysed and the
xpressed as percentages of WT Tax activities. The values reported are
type and mutant Tax proteins in the lysates were ascertained by
Figure 6 (See legend on next page.)
Turci et al. Retrovirology 2012, 9:102 Page 8 of 13
http://www.retrovirology.com/content/9/1/102
(See figure on previous page.)
Figure 6 Fusion of ubiquitin or SUMO-1 to the C-terminus of wild type or K1-10iR mutant modifies their intracellular localization
and increases NF-κB activity. (A) 293T cells were cotransfected with vectors expressing wild type or K1-10iR Tax-2B mutant, fused to
ubiquitin (Tax-2-Ub and Tax-2 K1-10iR-Ub) or SUMO-1 (Tax-2-SUMO and Tax-2 K1-10iR-SUMO). The cells were fixed and stained by dual
immunofluorescence staining with anti-Tax-2B rabbit polyclonal antibody and anti-RelA IgG1 monoclonal antibody. The secondary antibodies
were goat anti-rabbit IgG conjugated to Dylight 549 and goat anti-mouse IgG1 conjugated to Dylight 649. The images were collected using a
laser scanning confocal microscope. White arrows point to cytoplasmic structures at the boundary of the nucleus in which Tax-2-Ub and Tax-2
K1-10iR-Ub fusions colocalize with RelA. DIC, differential inference contrast. (B) 293T cells were cotransfected with 50 ng of vectors expressing
wild type or K1-10iR mutant Tax-2B fused or not to ubiquitin or SUMO-1 and 250 ng of the NF-κB-Luc reporter construct. 50 ng of the
phRG-TK Renilla Luciferase vector was added to normalize for transfection efficiency. Cells were lysed and the luciferase activity was measured
in each extracts. The activity of each mutant fusion is expressed as percentages relatively to the equivalent wild type Tax-2-Ub or Tax-2-SUMO
fusions. The values were normalized for equal quantity of Tax proteins in each extract. The values reported are the averages of three
independent experiments.
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correlation between the sumoylation status of Tax-1 and
Tax-2B mutants, their nuclear punctate distribution and
their capacities to activate the NF-κB pathway.
Fusion of ubiquitin or SUMO-1 to the C-terminus of
wild type or K1-10iR mutant Tax-2B modifies their
intracellular localization
To determine whether ubiquitination and sumoylation
had direct consequences on Tax-2B intracellular
localization and transcriptional activity, we constructed
fusions of ubiquitin or SUMO-1 to the C-terminus of
the lysine-less Tax-2 K1-10iR mutant (Tax-2 K1-10iR-Ub
and Tax-2 K1-10iR-SUMO). The equivalent fusions of
wild type Tax-2B (Tax-2-Ub and Tax-2-SUMO) were
constructed as controls. 293T cells transfected with
the various fusions were analyzed by dual immunofluor-
escence staining and confocal microscopy using anti-
Tax-2B and anti-RelA antibodies (Figure 6A).
Comparison of the results in Figure 6A with those
obtained in Figure 4 indicates that both wild type and
K1-10iR mutant Tax-2-Ub fusions colocalized in the ma-
jority of the cells with RelA in prominent cytoplasmic
structures localized at the boundary of the nucleus (indi-
cated by arrows in Figure 6A), contrary to their unfused
versions (see Figure 4). Immunostaining of GM130, a
Golgi matrix protein, and IKKγ, the regulatory subunit
of the IKK complexes, indicated that the cytoplasmic
structures containing the wild type Tax-2-Ub fusion
were closely associated with the Golgi apparatus and
concentrated IKKγ, in addition to RelA (Additional file 3).
These structures are reminiscent of the Tax-1/RelA/
IKKγ-containing cytoplasmic “hot spots” previously iden-
tified in Tax-1 and Tax-1-Ub expressing cells (see Figure 4
above and [22,23]). Interestingly, the Tax-2 K1-10iR-Ub
fusion was able to induce the migration of RelA to the
nucleus, contrary to the unfused Tax-2 K1-10iR mutant.
The wild type Tax-2-SUMO fusion was predominantly
distributed in prominent nuclear foci that included RelA,
and this fusion was less detected in the cytoplasm and
did not concentrate in cytoplasmic “hot spots”, ascompared to the Tax-2-Ub fusion. Furthermore, the Tax-
2 K1-10iR-SUMO fusion was distributed in nuclear foci,
contrary to the unfused K1-10iR mutant. This fusion
was able to induce the migration of RelA to the nucleus,
suggesting that fusion of SUMO-1 to the modification
deficient K1-10iR mutant can compensate the lack of
ubiquitination for activation of the IKK complexes in
the cytoplasm. Similar compensation of ubiquitination
by SUMO-1 fusion for induction of RelA migration to
the nucleus was previously observed for Tax-1 K4-8R-
SUMO fusion [22]. Thus, fusion of ubiquitin to the C-
terminus of the Tax-2 K1-10iR mutant determined the
targeting of the fusion to Golgi-associated structures
containing RelA and IKKγ, whereas fusion of SUMO-1
favored the formation of nuclear foci containing RelA.
In addition, both fusions were able to induce the trans-
location of RelA to the nucleus.
Fusion of ubiquitin or SUMO-1 to the C-terminus of the
K1-10iR Tax-2B mutant restores NF-κB activity
Finally, we tested whether fusion of ubiquitin or SUMO-
1 to wild type or K1-10iR Tax-2B resulted in altered
capacities to activate the NF-κB pathway. Figure 6B indi-
cates that the wild type Tax-2-Ub and Tax-2-SUMO
fusions had a markedly increased ability to activate the
NF-κB pathway as compared to the unfused wild type
Tax-2B control (9.6 and 2.4 fold increase, respectively).
In addition, although the unfused mutant K1-10iR was
deficient for activation of the NF-κB pathway (1% of wild
type unfused Tax-2B), ubiquitin or SUMO-1 fusion to
this mutant increased its transcriptional activity by 21
and 17 fold as compared to their wild type Tax-2-Ub
and Tax-2-SUMO controls, respectively. These results
strongly suggest that both ubiquitination and sumoyla-
tion are directly involved in Tax-2B-mediated activation
of the NF-κB pathway.
Discussion
We have compared the differences between the Tax pro-
teins of HTLV-1 and HTLV-2 that are involved in their
capacity to activate the NF-κB pathway. Tax-1-mediated
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nation and sumoylation of lysine residues in its central
domain and these modifications control Tax-1 intracel-
lular localization. We thus compared the modification
patterns of the two proteins by using a panel of lysine
to arginine substitution mutants. First, mutations of the
lysine residues in the central domain of the two proteins
(K4 to K8 for Tax-1 and K3ii to K8 for Tax-2B) resulted
in a significant decrease of the ubiquitination level
(12 and 24%, respectively), indicating that these central
lysine residues are major targets for ubiquitination. Sec-
ond, sumoylation, which is restricted to lysines K7 and
K8 for Tax-1, is targeted to all lysines of the central
domains in Tax-2B since only mutation of lysines K3ii to
K8 led to a marked reduction of Tax-2 sumoylation level
(7%). As expected, substitution of all lysine residues
in the two proteins led to ubiquitination and sumoyla-
tion deficiency.
Thus, the lysine usage for sumoylation differs between
Tax-1 and Tax-2B, which might indicate that the two
proteins have different tridimensional folding of their
central domain leading to differential interaction with
the sumoylation machinery. The differential lysine usage
for sumoylation has clear consequences on the intracel-
lular localization and transcriptional activity as indicated
by the observations that the sumoylation deficient Tax-1
K7-8R mutant does not assemble nuclear bodies and has
no transcriptional activity, contrary to the equivalent
Tax-2 K7-8R mutant.
Our results shed light on the differences reported in
the literature about Tax-2B distribution in the nucleus.
The comparative intracellular localization of Tax-1 and
Tax-2B has been thoroughly investigated [29-31], but
with controversial results. These studies support the idea
that Tax-2B is more predominant in the cytoplasm than
Tax-1 and that Tax-1 displays a striking punctate distri-
bution in the nucleus. By using various experimental
settings, we find out that overexpression of Tax-2B pre-
vents its detection in the nucleus and leads to its accu-
mulation in the cytoplasm. The level of expression
enabling efficient transport to the nucleus appears to
depend on the cellular background used for expression.
The comparative analysis of the ubiquitination pattern
of Tax-1 and Tax-2B points to a reduced representation
of the Tax-2B mono-ubiquitinated forms relatively to
Tax-1 (Figure 2), which might explain the differential
distribution of Tax-2B and Tax-1 in the cytoplasm and
the reduced transport of Tax-2B to the nucleus. This
suggestion is supported by the observation that fusion of
ubiquitin, which mimics mono-ubiquitination, favors the
concentration of Tax-2B (and Tax-1) in Golgi-associated
structures at the boundary of the nucleus. The contribu-
tion of these structures in Tax-1-mediated activation
of IKK complexes has been established [23,24].However, our previous observations suggest that these
cytoplasmic structures might also be involved in the
translocation of both Tax-1 and RelA to the nucleus.
Whether limited mono-ubiquitination controls the bal-
ance between nuclear and cytoplasmic Tax-2B, displacing
the equilibrium toward the cytoplasm, and whether the
cellular background and the level of expression affect
mono-ubiquitination of Tax-2B will require further
investigations. In addition, more work is required to
determine whether specific differences in the modifica-
tion patterns of Tax-1 and Tax-2B, including lysine usage
for sumoylation and level of mono-ubiquitination, might
impact their oncogenic potential.
Besides these differences, our work demonstrates that
both ubiquitination and sumoylation control Tax-2B
intracellular localization and ability to activate the NF-
κB pathway. Polyubiquitination, and specifically K63-
branched polyubiquitination, is a critical modifier of
several effectors of the NF-κB phosphorylation cascade
[32] as well as of Tax-1. Polyubiquitination of Tax-1 was
demonstrated to determine the targeting of IKKγ to
Golgi-associated structures involved in the activation of
the IKK complexes [22-25,33]. Similarly, Tax-2B poly-
ubiquitination could play a role in the release of RelA
sequestration by NF-κB inhibitors in the cytoplasm and
its subsequent migration to the nucleus. This conclusion
is supported by the correlation between the loss of ubi-
quitination of the lysine-less Tax-2 K1-10iR mutant and
its inability to induce the migration of RelA to the
nucleus. Furthermore, the striking increase in transcrip-
tional activity resulting from fusion of ubiquitin to the
C-terminus of both wild type and the lysine-less Tax-2B
mutant correlated with formation of cytoplasmic struc-
tures associated with the Golgi apparatus and the recruit-
ment of RelA and IKKγ to these structures.
Polysumoylation is involved in formation of nuclear
bodies by many cellular and viral proteins, including
Tax-1 [22,25,34]. The direct correlation between the
level of sumoylation of Tax-2B lysine mutants and
SUMO-1 fusion to the lysine-less mutant, their ability to
form punctate nuclear structures that included RelA and
p300 and to activate gene expression via the NF-κB
pathway support the idea that sumoylation and target-
ing to punctate nuclear structures play critical roles in
Tax-2B transcriptional activity.
The concept that SUMO modification of Tax proteins
plays an active role in activation of the NF-κB pathway
[22,25,28-30] reviewed in [20,21] is challenged by a
new study by Bonnet et al. [35]. The study shows that a
Tax-1 mutant (P79AQ81A) with sumoylation that is
only 23% of wild type Tax-1 and reduced ability to form
detectable NBs is still transcriptionally active. Such
results might be reconciled with our observations if
the Tax-1 mutant P79AQ81A maintains a level of
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governing the relationship between sumoylation and
transcriptional activity is in line with the well known
observation that the biological consequences of SUMO
conjugation is not proportional to the small fraction of
substrate that is modified [36]. In addition, detection
of NBs at the resolution level of light microscopy might
require a sumoylation threshold higher than that
required for transcriptional activity. If we assume that
Tax NBs are sites of transcription, it is interesting to
note that the estimated size of transcription factories is
70-80 nm [37], which is considerably under the reso-
lution of immunofluorescence staining and confocal
microscopy. Thus, detection of Tax NBs might depend
on overexpression of Tax or Tax-SUMO fusion, but
might be limited in cells expressing Tax-1 mutant
P79AQ81A or in HTLV-1 infected T-lymphocytes. These
suggestions are supported by the observation that Tax-1
mutant K7R, which has a reduced sumoylation status
(30% of wild type Tax-1), gives both NB formation
and transcriptional activity similar to the phenotype of
mutant P79AQ81A [35]. In a recent paper, Xiao [38]
concludes that the studies of Bonnet et al. [35] cannot
rule out the possibility that Tax sumoylation and/or nu-
clear bodies may be involved in the transcriptional regu-
lation of some specific NF-κB target genes.
This study supports the idea that both Tax-1 and Tax-
2B need to be targeted to specific subcellular domains to
achieve NF-κB activation and broadens our model
depicting the cytoplasmic and nuclear steps involved in
Tax-1-mediated activation of the NF-κB pathway [22]. In
addition, Tax-1 and Tax-2B have common partners both
in the cytoplasm and nucleus. The results of this study,
showing that the punctate nuclear structures assembled
by Tax-2B include the RelA subunit of NF-κB and the
p300 transcriptional coactivator, indicate a common
property with the previously identified Tax-1 NBs. This
work is also consistent with our previous studies show-
ing that Tax-2B and Tax-1 colocalize in the cytoplasm
with cellular effectors of the NF-κB pathway activation
pathway RelA, IKKγ and TAB2 [30].
Conclusions
A huge body of evidence indicates that the transforming
activity of Tax-1 depends on its capacity to activate the
NF-κB pathway. However, this property is most likely
necessary but not sufficient for cellular transformation.
Since Tax-2B activates the NF-κB pathway to similar
level and via similar mechanisms, the lack of malignancy
of HTLV-2 might result from other functional properties
that differ between Tax-1 and Tax-2B such as activation
of the non-canonical NF-κB pathway, interaction with
PDZ-domain proteins and/or other properties yet to
be revealed.Methods
Plasmid constructs
The alignment and nomenclature of the lysine residues
in Tax-1 and Tax-2B are shown in Figure 1. The plasmid
constructs expressing the wild type or lysine to argi-
nine substitution mutants K7-8R, K4-8R and K1-10R of
Tax-1 fused to a C-terminal 6-histidine tag were as
previously described [22]. The pcDNA-Tax-1 vector
obtained by replacing the sequence coding for Tax-1F in
pcDNA6.2 Tax-1F expression vector [29] by the se-
quence coding for Tax-1. The Tax-2B cDNA was cloned
into both the pJFE14 vector [39] and the pcDNA6.2/N
expression vector (Invitrogen Corporation; Carlsbad, Ca,
USA) using EcoRI restriction sites. A similar construct
generated pcDNA6.2-Tax-2-6His. This construct was
submitted to site-directed mutagenesis to generate the
plasmids expressing the Tax-2-6His K7-8R, K3ii-8R and
K1-10iR mutants using the Stratagene mutagenesis kit.
The vectors for the expression of wild type or K1-10iR
mutant Tax-2B fusions to ubiquitin or SUMO-1 were
obtained by PCR amplification of the ubiquitin or
SUMO-1 coding sequence followed by a 6 histidine tag
and the cloning of the resulting fragments at the 3’ end
of the Tax coding sequence in vectors pcDNA6.2-Tax-2
and pcDNA6.2-Tax-2 K1-10iR. The di-glycine motif
involved in the conjugation reaction at the end of
the ubiquitin and SUMO-1 sequences were replaced by
Gly-Ala to prevent conjugation of the fusions to other
substrates. Each mutant or fusion was submitted to
nucleotide sequence analysis to verify the correct
nucleotide sequence and mutations. The vectors expressing
ubiquitin or SUMO-1 tagged with the hemagglutinin epi-
tope of the Influenza virus (HA) at their N-terminus
have been previously described [40,41]. The vector for
expression of p300-HA has been previously described
[42]. The reporter plasmid NF-κB LTR-luc was pur-
chased from Stratagene.
Cell culture and transfection
293T and HeLa cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 2
mM L-Glutamine, 10% foetal calf serum (FCS), 1%
penicillin-streptomycin and 1 mM sodium pyruvate
(Gibco) and transfected using the Transit LT1 reagent
(Mirus Bio LLC) according to the manufacturer’s
instructions.
Antibodies
The Tax-2B polyclonal antibody was obtained by immu-
nizing rabbits with a peptide sequence representing
the 20 C-terminal amino acids of Tax-2B (AAQ-
GESSTQKVRPSHTNNPK). The antibody was further
purified by affinity chromatography against the immo-
bilized peptide. Its binding specificity was determined
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(Additional file 1). The anti-Tax-1 monoclonal antibody
from hybridoma 168-A51 was obtained from the AIDS
research and Reagent Program, National Institutes of
Health. The anti-RelA IgG1 mouse monoclonal antibody
(F-6), the anti-HA IgG2a monoclonal antibody (F-7), the
anti-HA rabbit polyclonal antibody (Y-11) and the anti-
IKKγ IgG1 monoclonal antibody (B-3) were purchased
from Santa Cruz Biotechnology. The anti-p300 IgG1
mouse monoclonal antibody (RW128) was from Upstate.
The anti-pentaHis mouse antibody was from Qiagen.
The anti-GM130 was from BD Biosciences. The second-
ary antibodies used for immunofluorescence staining
were Dylight 488-conjugated goat anti-mouse IgG2a,
Dylight 549- or 488-conjugated goat anti-rabbit IgG
and Dylight 649-conjugated goat anti-mouse IgG1 from
Jackson ImmunoResearch.
Luciferase assays
Tax-1- and Tax-2B-mediated activation of gene expres-
sion via the NF-κB pathway was assayed by dual lucifer-
ase assays using the NF-κB-luc reporter construct. 293T
cells (1.25 x 105) were transfected into 12 wells with
250 ng of NF-κB-luc reporter plasmids, 50 ng of each of
the different Tax-1 or Tax-2B constructs, and 50 ng of
phRG-TK Renilla Luciferase vector (Promega) used to
monitor transfection efficiency. Cells were lysed and
tested for luciferase activity with a luminometer TD-20/
20 (Turner Designs) using the Dual-luciferase reporter
assay system (Promega).
Ni-NTA pulldown and western blot analysis
293T cells were lysed 24 h after transfection and Ni-
NTA pulldown was done as described previously [22].
The purified proteins were analyzed by electrophoresis
on 4-12% Bis-Tris NuPAGE gel (Invitrogen), transferred
to Hybond ECL Nitrocellulose membrane (Amersham
Pharmacia Biotech), and immunoblotted with primary
and corresponding secondary antibodies. Detection was
by Lumi-Light Western Blotting Substrate (Roche) or
Chemi-luminescent Peroxidase Substrate (Sigma Aldrich).
Detection and quantitation of chemiluminescent signals
were performed with the Chemi-Smart 5000 and Bio-1D
software (Vilber Lourmat) or Autochemi and Gel Pro
Analyzer (UVP BioImaging Systems).
Immunofluorescence staining
Cells cultured on glass coverlips were transfected with
expression plasmids for 24 h, fixed in Immunohistofix
(Gentaur) at room temperature for 10 minutes followed
by incubation in methanol for 6 minutes at -20°C and
incubated with the primary antibodies overnight at 4°C.
After washing, the specimens were incubated for 2 h
at room temperature with the secondary antibodies.Analysis was with a laser scanning confocal microscope
(LSM 510, Zeiss) equipped with a 63x objective and light
source wavelengths of 488, 543 and 633 nm.
Additional files
Additional file 1: Specificity of the purified anti-Tax-2B rabbit
polyclonal antibody. Total cell lysates (30 μg) from 293T cells expressing
either Tax-2B or Tax-1 were analyzed (A) by Western blotting with the
purified rabbit polyclonal anti-Tax-2B antibody developed in this work
(1:2000 dilution). (B) These lysates were also immunoprecipitated with the
same anti-Tax-2B antibody. The input represents 1/10 of the
immunoprecipitated lysate.
Additional file 2: Tax-1 and Tax-2B colocalize with endogenous
p300 in nuclear punctate structures. 293T cells were either transfected
or not with the vectors expressing Tax-1 or Tax-2B. The cells were fixed
and analyzed by dual immunofluorescence staining with the anti-Tax-1
IgG2a monoclonal antibody or the anti-Tax-2B rabbit polyclonal antibody
and an anti-p300 IgG1 monoclonal antibody. The secondary antibodies
were goat anti-mouse IgG2a conjugated to Dylight 488, goat anti-mouse
IgG1 antibody conjugated to Dylight 649 and goat anti-rabbit IgG
antibody conjugated to Dylight 549. The images were collected using a
laser scanning confocal microscope. DIC, differential inference contrast.
Additional file 3: The wild type Tax-2B fusion to ubiquitin
colocalizes with IKKγ in prominent cytoplasmic structures closely
associated with the Golgi apparatus. 293T cells transfected or not with
the vector expressing the Tax-2-Ub fusion were fixed and analyzed by
dual immunofluorescence staining with anti-Tax-2B rabbit polyclonal
antibody and (A) anti-GM130 IgG1 mouse monoclonal antibody or (B)
anti-IKKγ IgG1 mouse monoclonal antibody. The secondary antibodies
were goat anti-mouse IgG1 antibody conjugated to Dylight 649 and goat
anti-rabbit IgG antibody conjugated to Dylight 549. The images were
collected using a laser scanning confocal microscopy. DIC, differential
inference contrast.
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